Wu et al. [1] found that HPRT1 regulates cisplatin resistance to cisplatin in oral squamous cell carcinoma by positively regulating the expression of matrix metallopeptidase and activating the phosphoinositide 3-kinase/AKT pathway. Here, HPRT1 is linked to oral cavity squamous cell carcinoma.